CreosG Secures Next-Generation Muscle Growth Health Functional Food Business Rights as a 'Protein Drink Alternative'

CreoESG has embarked on a joint research project on the anti-aging substance ‘CAF (Cell Activation Factor)’ with the natural products specialist company ‘Hepatol’ and is now entering the health functional food (HFF) business based on commercialized products. CreoESG announced on the 27th that it has signed a memorandum of understanding (MOU) with Hepatol for the ‘development and business progress of anti-aging and muscle growth HFF products using CAF.’

With this MOU as a milestone, CreoESG has secured the global business rights for the CAF-based HFF product ‘MUSCLO.’ Through cooperation, the two companies plan to sell MUSCLO not only in Korea but also in global markets such as China and Japan, while continuously developing new products. Hepatol is already selling CAF-based medical foods in Europe and has secured raw materials for product manufacturing as well as domestic and international distribution networks.

CreoESG plans to launch MUSCLO domestically and internationally after verifying its muscle growth effects through clinical trials. Recently, the U.S. Food and Drug Administration (FDA) announced that preventing muscle loss can help prevent most age-related diseases, including dementia. The company explained that in a one-month clinical trial targeting the elderly, MUSCLO was confirmed to effectively increase skeletal muscle and bone density, which is expected to attract attention in the global market.

Existing protein drinks are consumed by various age groups for muscle growth and maintenance. Unlike protein drinks, MUSCLO helps muscle growth based on metabolism, so it has the advantage of not causing side effects such as gout, kidney stones, or osteoporosis.

A CreoESG official said, “MUSCLO is a next-generation health functional food that participates in the body’s fat metabolism process to reduce body fat and improve fatty liver, hyperlipidemia, obesity, and diabetes. It is expected to replace the protein drink market because it not only prevents various side effects caused by existing protein drinks but also eliminates the need for excessive exercise for muscle growth.”

He added, “The efficacy and safety of CAF have already been verified in the U.S., Europe, and other regions, and raw material procurement and distribution network establishment for the HFF business have been completed, enabling rapid business development. Through this MOU, we will carry out the CAF-based HFF business in domestic and international markets to secure a new cash cow for CreoESG.”